Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:33 PM
Ignite Modification Date:
2025-12-24 @ 11:33 PM
NCT ID:
NCT03395756
Eligibility Criteria:
Inclusion Criteria:
* Healthy women of reproductive age (18-39 years old) with BMI 18-30 kg/m2
* Regular menses for the last 3 months
* Cycle duration 24 to 35 days
* Women using copper IUD, sterilization, or barrier methods as current or preferred birth control method, and women reporting exclusive sex with women
* English- or Spanish-speaking
Exclusion Criteria:
* Any contraindications to progesterone contraception per teh CDC Medical Eligibility Criteria (Category 3 or 4)
* On medications that can alter, or be altered by, progesterone contraceptive steroid hormone (e.g., aminoglutethimide or other anti-steroid medication)
* Use of any hormonal contraceptive pill, patch, or vaginal ring in the month prior to recruitment
* Use of depot-medroxyprogesterone acetate in teh 10 months prior to recruitment
* Currently pregnant and/or breastfeeding
* History of allergic reaction to depot medroxyprogesterone acetate (rash, urticaria, anaphylaxis)
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
39 Years
Study:
NCT03395756
Study Brief:
Protocol Section:
NCT03395756